NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.
A role for the NADPH oxidases NOX1 and NOX2 in liver fibrosis has been proposed, but the implication of NOX4 is poorly understood yet. The aim of this work was to study the functional role of NOX4 in different cell populations implicated in liver fibrosis: hepatic stellate cells (HSC), myofibroblats...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23049784/?tool=EBI |
id |
doaj-75617722b61f41f39952517e7d2fb884 |
---|---|
record_format |
Article |
spelling |
doaj-75617722b61f41f39952517e7d2fb8842021-03-04T00:15:43ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0179e4528510.1371/journal.pone.0045285NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.Patricia SanchoJèssica MainezEva Crosas-MolistCésar RonceroConrado M Fernández-RodriguezFernando PinedoHeidemarie HuberRobert EferlWolfgang MikulitsIsabel FabregatA role for the NADPH oxidases NOX1 and NOX2 in liver fibrosis has been proposed, but the implication of NOX4 is poorly understood yet. The aim of this work was to study the functional role of NOX4 in different cell populations implicated in liver fibrosis: hepatic stellate cells (HSC), myofibroblats (MFBs) and hepatocytes. Two different mice models that develop spontaneous fibrosis (Mdr2(-/-)/p19(ARF-/-), Stat3(Δhc)/Mdr2(-/-)) and a model of experimental induced fibrosis (CCl(4)) were used. In addition, gene expression in biopsies from chronic hepatitis C virus (HCV) patients or non-fibrotic liver samples was analyzed. Results have indicated that NOX4 expression was increased in the livers of all animal models, concomitantly with fibrosis development and TGF-β pathway activation. In vitro TGF-β-treated HSC increased NOX4 expression correlating with transdifferentiation to MFBs. Knockdown experiments revealed that NOX4 downstream TGF-β is necessary for HSC activation as well as for the maintenance of the MFB phenotype. NOX4 was not necessary for TGF-β-induced epithelial-mesenchymal transition (EMT), but was required for TGF-β-induced apoptosis in hepatocytes. Finally, NOX4 expression was elevated in patients with hepatitis C virus (HCV)-derived fibrosis, increasing along the fibrosis degree. In summary, fibrosis progression both in vitro and in vivo (animal models and patients) is accompanied by increased NOX4 expression, which mediates acquisition and maintenance of the MFB phenotype, as well as TGF-β-induced death of hepatocytes.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23049784/?tool=EBI |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Patricia Sancho Jèssica Mainez Eva Crosas-Molist César Roncero Conrado M Fernández-Rodriguez Fernando Pinedo Heidemarie Huber Robert Eferl Wolfgang Mikulits Isabel Fabregat |
spellingShingle |
Patricia Sancho Jèssica Mainez Eva Crosas-Molist César Roncero Conrado M Fernández-Rodriguez Fernando Pinedo Heidemarie Huber Robert Eferl Wolfgang Mikulits Isabel Fabregat NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development. PLoS ONE |
author_facet |
Patricia Sancho Jèssica Mainez Eva Crosas-Molist César Roncero Conrado M Fernández-Rodriguez Fernando Pinedo Heidemarie Huber Robert Eferl Wolfgang Mikulits Isabel Fabregat |
author_sort |
Patricia Sancho |
title |
NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development. |
title_short |
NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development. |
title_full |
NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development. |
title_fullStr |
NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development. |
title_full_unstemmed |
NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development. |
title_sort |
nadph oxidase nox4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2012-01-01 |
description |
A role for the NADPH oxidases NOX1 and NOX2 in liver fibrosis has been proposed, but the implication of NOX4 is poorly understood yet. The aim of this work was to study the functional role of NOX4 in different cell populations implicated in liver fibrosis: hepatic stellate cells (HSC), myofibroblats (MFBs) and hepatocytes. Two different mice models that develop spontaneous fibrosis (Mdr2(-/-)/p19(ARF-/-), Stat3(Δhc)/Mdr2(-/-)) and a model of experimental induced fibrosis (CCl(4)) were used. In addition, gene expression in biopsies from chronic hepatitis C virus (HCV) patients or non-fibrotic liver samples was analyzed. Results have indicated that NOX4 expression was increased in the livers of all animal models, concomitantly with fibrosis development and TGF-β pathway activation. In vitro TGF-β-treated HSC increased NOX4 expression correlating with transdifferentiation to MFBs. Knockdown experiments revealed that NOX4 downstream TGF-β is necessary for HSC activation as well as for the maintenance of the MFB phenotype. NOX4 was not necessary for TGF-β-induced epithelial-mesenchymal transition (EMT), but was required for TGF-β-induced apoptosis in hepatocytes. Finally, NOX4 expression was elevated in patients with hepatitis C virus (HCV)-derived fibrosis, increasing along the fibrosis degree. In summary, fibrosis progression both in vitro and in vivo (animal models and patients) is accompanied by increased NOX4 expression, which mediates acquisition and maintenance of the MFB phenotype, as well as TGF-β-induced death of hepatocytes. |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23049784/?tool=EBI |
work_keys_str_mv |
AT patriciasancho nadphoxidasenox4mediatesstellatecellactivationandhepatocytecelldeathduringliverfibrosisdevelopment AT jessicamainez nadphoxidasenox4mediatesstellatecellactivationandhepatocytecelldeathduringliverfibrosisdevelopment AT evacrosasmolist nadphoxidasenox4mediatesstellatecellactivationandhepatocytecelldeathduringliverfibrosisdevelopment AT cesarroncero nadphoxidasenox4mediatesstellatecellactivationandhepatocytecelldeathduringliverfibrosisdevelopment AT conradomfernandezrodriguez nadphoxidasenox4mediatesstellatecellactivationandhepatocytecelldeathduringliverfibrosisdevelopment AT fernandopinedo nadphoxidasenox4mediatesstellatecellactivationandhepatocytecelldeathduringliverfibrosisdevelopment AT heidemariehuber nadphoxidasenox4mediatesstellatecellactivationandhepatocytecelldeathduringliverfibrosisdevelopment AT roberteferl nadphoxidasenox4mediatesstellatecellactivationandhepatocytecelldeathduringliverfibrosisdevelopment AT wolfgangmikulits nadphoxidasenox4mediatesstellatecellactivationandhepatocytecelldeathduringliverfibrosisdevelopment AT isabelfabregat nadphoxidasenox4mediatesstellatecellactivationandhepatocytecelldeathduringliverfibrosisdevelopment |
_version_ |
1714810444530581504 |